Tagzon-S 750 Injection
Marketer
Atsun Life Sciences
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Tagzon-S 750 Injection
Cefixime and Sulbactam 750mg Injection is a dual-action antibiotic prescribed for diverse bacterial infections. Its mechanism combats microbial proliferation, halting infection spread. Administration must be strictly under medical supervision; adherence to the prescribed dosage schedule is crucial. Complete the entire course, even with symptom improvement, as premature cessation can compromise its effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor of all current medications, particularly if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and hydration are essential for optimal recovery. Your physician may order lab tests to monitor treatment efficacy.
Uses of Tagzon-S 750 Injection
Infections caused by bacteria
Major Benefits of Tagzon-S 750 Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Tagzon-S 750 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Tagzon-S 750 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Tagzon-S 750 Injection works:
Ceftriaxone and Sulbactam, the active components of Tagzon-S 750 Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Tagzon-S 750 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Tagzon-S 750 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
Administering Tagzon-S 750 Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Tagzon-S 750 Injection can lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Tagzon-S 750 Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Exercise caution when administering Tagzon-S 750 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alteration for Tagzon-S 750 Injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Tagzon-S 750 Injection :
Omit a scheduled Tagzon-S 750 Injection? Seek your physician's advice.
Facts to Know About Tagzon-S 750 Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Antimicrobial agents |
3,018 People bought this recently